Plasmodium falciparum hemozoin

Plasmodium falciparum hemozoin, often referred to as malaria pigment, is a biocrystal formed within the parasite's acidic food vacuole as a mandatory detoxification product of hemoglobin digestion (PubMed: 11375458). During the intraerythrocytic stage of its life cycle, the parasite catabolizes host hemoglobin to acquire essential amino acids, a process that releases large quantities of free heme (ferriprotoporphyrin IX). Because free heme is highly toxic to the parasite due to its ability to generate reactive oxygen species and disrupt lipid membranes, the parasite sequesters it into insoluble, chemically inert hemozoin crystals (NIH: PMC3104478). This crystallization process is a critical survival mechanism and serves as a primary therapeutic target for several classes of antimalarial drugs. Compounds such as chloroquine and quinine interfere with this process by binding to the growing crystal faces or forming complexes with free heme, thereby preventing further polymerization (StatPearls: NBK551512). The resulting accumulation of toxic heme leads to the destruction of the parasite's internal membranes and its eventual death. While highly effective, the utility of drugs targeting hemozoin is increasingly challenged by the emergence of resistance, often mediated by mutations in vacuolar transporters like PfCRT (UniProt: Q9N600).

Other names

HemozoinMalaria pigmentFerriprotoporphyrin IX aggregatesbeta-hematinHeme crystals

Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic free ferriprotoporphyrin IX.